Sign In
Buy DXCM
$72.59
-0.180 (-0.247%)
At Close: Jun 04, 2026
Watch These Dexcom Price Levels as Stock Plunges After Guidance Slashed
10:01pm, Thursday, 25'th Jul 2024
Shares in Dexcom (DXCM) lost more than a third of their value in extended trading Thursday after the medical devices company posted second-quarter results that came in below Wall Street expectations a
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
09:53pm, Thursday, 25'th Jul 2024
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) investors concerning the Company
DexCom, Inc. (DXCM) Q2 2024 Earnings Call Transcript
09:09pm, Thursday, 25'th Jul 2024
DexCom, Inc. (NASDAQ:DXCM ) Q2 2024 Earnings Conference Call July 25, 2024 4:30 PM ET Corporate Participants Sean Christensen - Vice President of Finance, and Investor Relations Kevin Sayer - Chairman
DexCom (DXCM) Q2 Earnings Surpass Estimates
06:15pm, Thursday, 25'th Jul 2024
DexCom (DXCM) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.34 per share a year ago.
Dexcom Stock Plummets on Earnings Miss, Guidance Cut
05:56pm, Thursday, 25'th Jul 2024
Shares of Dexcom (DXCM) tumbled over 40% in extended trading Thursday after the company reported second-quarter earnings that missed estimates and slashed its full-year revenue guidance.
Dexcom shares plummet 30% after company lowers fiscal year guidance
04:17pm, Thursday, 25'th Jul 2024
Dexcom shares plummet 30% after company lowers fiscal year guidance
CGM Sensor Demand Likely to Drive DexCom (DXCM) Q2 Earnings
08:36am, Tuesday, 23'rd Jul 2024
DexCom's (DXCM) second-quarter 2024 results are likely to reflect rising volumes across all channels.
The Zacks Analyst Blog DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific
04:46am, Tuesday, 16'th Jul 2024
DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific are included in this Analyst Blog.
Here's Why DexCom (DXCM) is a Strong Growth Stock
10:45am, Monday, 15'th Jul 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Buy 5 Medical Devices Stocks to Enhance Your Portfolio in 2H
09:12am, Monday, 15'th Jul 2024
We have narrowed our search to five Medical Instruments stocks. These are: DXCM, TMO, ISRG, ALC, HOLX.
2 Healthcare Stocks to Buy at a Discount
10:00am, Sunday, 14'th Jul 2024
Investors are showing varying degrees of appetite for the telehealth and diabetes care industries. Teladoc has undergone major changes in recent years, and investors are warily eyeing its path forward
Top 4 Must-Have Healthcare Stocks for Long-Term Growth
11:11am, Thursday, 11'th Jul 2024
The healthcare industry represents a substantial and dynamic market sector, presenting many opportunities for investors seeking long-term growth and stability. Factors such as the aging population, te
DexCom (DXCM), Abbott to Launch First FDA Cleared OTC CGMs
12:55pm, Friday, 05'th Jul 2024
Dexcom (DXCM) and Abbott are set to launch their first FDA-approved over-the-counter CGMs, Stelo and Lingo & Libre Rio, respectively, in the United States this summer.
2 Top Growth Stocks to Buy With $1,000
10:00am, Thursday, 04'th Jul 2024
E-commerce powerhouse Shopify has a solid moat and plenty of room to run. DexCom's massive addressable market bodes well for its long-term prospects.
DexCom's ADA Conference Takeaways: Stelo, CGM Tailwinds Still Intact
11:27am, Wednesday, 03'rd Jul 2024
DexCom presented outlook on diabetes market at the ADA Conference, highlighting potential for growth with new products like Stelo and DexCom ONE. DexCom's strategy differs from Abbott Labs, focusing o
